<DOC>
	<DOCNO>NCT01915511</DOCNO>
	<brief_summary>This registry collect data strategy use achieve diagnosis Idiopathic Pulmonary Fibrosis ( IPF ) treatment management effort apply throughout study follow-up , clinical outcome event patient report outcome data . Blood sample collect periodically throughout study use future research effort .</brief_summary>
	<brief_title>Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Willing able provide inform consent Established new diagnosis IPF enrol subspecialty center ( define ATS/ERS/JRS/ALAT criterion ) Age &gt; 40 year old Previously diagnose IPF enrol subspecialty center . Only participant newly diagnose IPF include . Malignancy , treat untreated , skin cancer , within past 5 year Currently list lung transplantation time enrollment Currently enrol randomize clinical trial time enrollment registry</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
	<keyword>Pulmonary fibrosis</keyword>
	<keyword>IPF</keyword>
	<keyword>Registry</keyword>
	<keyword>1199.174</keyword>
</DOC>